[Bronchodilator agents].
D000109:Acetylcholine / Q000009:adverse effects / Q000378:metabolism; D001980:Bronchi / Q000187:drug effects; D001986:Bronchial Spasm / Q000139:chemically induced / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D000242:Cyclic AMP; D006493:Heparin / Q000009:adverse effects; D006632:Histamine / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010276:Parasympatholytics / Q000627:therapeutic use; D012701:Serotonin / Q000009:adverse effects; D013566:Sympathomimetics; D014970:Xanthines / Q000627:therapeutic use
D001993:Bronchodilator Agents; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D013566:Sympathomimetics; D014970:Xanthines; D012701:Serotonin; D006632:Histamine; D006493:Heparin; D000242:Cyclic AMP; D000109:Acetylcholine; D009638:Norepinephrine
Brongodilatoriese Middels.